menu
    • menu

    Company profile for Sirius Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sirius is an innovative biotech company focused on developing novel RNAi therapies for global markets. The company is dedicated to providing solutions for physicians and patients to manage cardiovascular diseases. Founded in 2021, Sirius has a world-class leadership team and investors. The company established an innovation, research, and development center in the United States and a translational center in China to address u...
    Sirius is an innovative biotech company focused on developing novel RNAi therapies for global markets. The company is dedicated to providing solutions for physicians and patients to manage cardiovascular diseases. Founded in 2021, Sirius has a world-class leadership team and investors. The company established an innovation, research, and development center in the United States and a translational center in China to address unmet patient needs in chronic diseases. Leveraging RNAi technology, Sirius aims to offer a portfolio of solutions for patients to change the future of cardiovascular disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sirius TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11760 Sorrento Valley Road, San Diego, California 92121
    Telephone
    Telephone
    +1 8583580096
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.siriusrna.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crucial Step: Crispr & Sirius Start Phase 2 Trial Of Srsd107
    Crucial Step: Crispr & Sirius Start Phase 2 Trial Of Srsd107

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153917/0/en/CRISPR-Therapeutics-and-Sirius-Therapeutics-Announce-First-Patient-Dosed-in-Phase-2-Trial-of-SRSD107-for-Thromboembolic-Disorders-in-Europe.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    CRISPR and Sirius Therapeutics Collaborate on siRNA Therapies
    CRISPR and Sirius Therapeutics Collaborate on siRNA Therapies

    19 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/19/3084420/0/en/CRISPR-Therapeutics-and-Sirius-Therapeutics-Announce-Multi-Target-Collaboration-to-Develop-Novel-siRNA-Therapies.html

    GLOBENEWSWIRE
    19 May 2025
    Share Share
    Sirius Therapeutics Secures $50M Financing for siRNA Therapeutics
    Sirius Therapeutics Secures $50M Financing for siRNA Therapeutics

    09 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250507421040/en/Sirius-Therapeutics-Announces-Nearly-%2450-Million-Financing-to-Accelerate-Clinical-Development-of-siRNA-Therapeutics-for-Cardiometabolic-Diseases

    BUSINESSWIRE
    09 May 2025
    Share Share
    Sirius Reports Phase I Data On Long-Acting Anticoagulant
    Sirius Reports Phase I Data On Long-Acting Anticoagulant

    10 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241209815845/en

    BUSINESSWIRE
    10 Dec 2024
    Share Share
    Sirius Therapeutics to Present Phase 1 Data at ASH Annual Meeting
    Sirius Therapeutics to Present Phase 1 Data at ASH Annual Meeting

    02 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241202142345/en

    BUSINESSWIRE
    02 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search